Agios Pharmaceuticals (AGIO) Financials: History & Chart

Compare

Agios Pharmaceuticals, Inc.(AGIO)

Biotechnology · Cambridge, MA

$31.71+0.46 (+1.47%)

Delayed quote: Oct 6, 2026, 11:50 AM EDT

Compare

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	98.34M	44.74M	20.75M	19.97M	12.88M	12.46M	8.73M	10.73M	8.96M
Cost of Goods Sold	11.88M	3.00M	2.68M	3.15M	3.05M	2.96M	2.36M	1.26M	783K
Gross Profit	86.46M	41.75M	18.06M	16.82M	9.83M	9.49M	6.36M	9.47M	8.18M
Gross Profit Margin	87.9%	93.3%	87.1%	84.2%	76.3%	76.2%	72.9%	88.3%	91.3%
Total Operating Expenses	545.49M	152.30M	128.09M	138.40M	126.70M	136.55M	112.99M	134.51M	110.99M
Research & Development	352.75M	100.75M	79.78M	86.79M	85.42M	90.68M	71.47M	82.81M	72.45M
Selling, General & Administrative	192.74M	51.55M	48.30M	51.61M	41.27M	45.87M	41.53M	51.70M	38.54M
Operating Income (EBIT)	-459.02M	-110.55M	-110.03M	-121.58M	-116.87M	-127.06M	-106.63M	-125.04M	-102.81M
Operating Margin	-466.8%	-247.1%	-530.3%	-608.9%	-907.4%	-1020.1%	-1222.0%	-1165.3%	-1146.9%
Income Before Tax (EBT)	-412.30M	-100.70M	-99.11M	-109.06M	-103.43M	-112.02M	-89.29M	-105.40M	1.00B
Interest Income	46.30M	9.73M	10.79M	12.41M	13.37M	14.51M	16.09M	18.02M	13.06M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	46.72M	9.85M	10.91M	12.52M	13.44M	15.04M	17.34M	19.64M	1.10B
Net Income	-411.29M	-100.70M	-99.11M	-108.04M	-103.43M	-112.02M	-89.29M	-96.52M	947.91M
Income Tax Expense	-1.02M	0.00	0.00	-1.02M	0.00	0.00	0.00	-8.88M	53.12M
Net Profit Margin	-418.2%	-225.1%	-477.7%	-541.1%	-803.1%	-899.4%	-1023.3%	-899.6%	10574.7%
EBITDA	-453.67M	-109.20M	-108.66M	-120.31M	-115.50M	-125.80M	-105.35M	-123.67M	-101.47M
EBITDA Margin	-461.3%	-244.1%	-523.8%	-602.6%	-896.7%	-1010.0%	-1207.3%	-1152.6%	-1131.9%
Depreciation & Amortization	5.35M	1.35M	1.36M	1.27M	1.37M	1.26M	1.28M	1.37M	1.34M
EPS Basic	-7.01	-1.69	-1.69	-1.85	-1.78	-1.93	-1.55	-1.69	16.65
EPS Diluted	-7.01	-1.69	-1.69	-1.85	-1.78	-1.93	-1.55	-1.69	16.22
Weighted Average Basic Shares	59.49M	59.49M	58.78M	58.33M	58.14M	57.93M	57.46M	57.16M	56.94M
Weighted Average Diluted Shares	59.49M	59.49M	58.78M	58.33M	58.14M	57.93M	57.46M	57.16M	58.43M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	54.03M	36.50M	26.82M	14.24M	0.00	0.00	117.91M	94.39M
Cost of Goods Sold	11.52M	4.17M	9.50M	1.70M	18.78M	18.77M	1.32M	1.40M
Gross Profit	42.51M	32.33M	17.32M	12.54M	-18.78M	-18.77M	116.59M	92.99M
Gross Profit Margin	78.7%	88.6%	64.6%	88.0%	N/A	N/A	98.9%	98.5%
Total Operating Expenses	514.64M	458.07M	408.81M	401.58M	359.64M	317.14M	542.93M	455.47M
Research & Development	334.36M	301.29M	288.90M	279.91M	256.97M	211.02M	410.89M	341.32M
Selling, General & Administrative	180.28M	156.78M	119.90M	121.67M	121.44M	106.12M	132.03M	114.14M
Operating Income (EBIT)	-472.13M	-425.74M	-391.49M	-389.05M	-378.42M	-335.92M	-426.33M	-362.48M
Operating Margin	-873.9%	-1166.5%	-1459.5%	-2732.1%	N/A	N/A	-361.6%	-384.0%
Income Before Tax (EBT)	-413.80M	717.97M	-352.09M	-231.80M	-356.51M	-329.31M	-411.47M	-346.03M
Interest Income	56.38M	48.08M	33.34M	12.79M	836K	6.61M	14.86M	16.45M
Interest Expense	N/A	N/A	N/A	N/A	N/A	17.83M	N/A	N/A
Other Income/Expense	58.34M	1.14B	39.40M	157.25M	21.91M	6.61M	14.86M	16.45M
Net Income	-412.78M	673.73M	-352.09M	-231.80M	1.60B	-327.37M	-411.47M	-346.03M
Income Tax Expense	-1.02M	44.24M	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-764.0%	1845.9%	-1312.6%	-1627.8%	N/A	N/A	-349.0%	-366.6%
EBITDA	-466.95M	-420.08M	-384.86M	-380.48M	-359.64M	-317.14M	-409.71M	-355.31M
EBITDA Margin	-864.3%	-1151.0%	-1434.8%	-2671.9%	N/A	N/A	-347.5%	-376.4%
Depreciation & Amortization	5.18M	5.65M	6.62M	8.56M	18.78M	18.77M	16.62M	7.17M
EPS Basic	-7.12	11.86	-6.33	-4.23	N/A	-4.74	-6.61	-6.03
EPS Diluted	-7.12	11.64	-6.33	-4.23	N/A	-4.74	-6.61	-6.03
Weighted Average Basic Shares	57.97M	56.81M	55.65M	54.79M	60.45M	69.00M	59.99M	57.42M
Weighted Average Diluted Shares	57.97M	57.89M	55.65M	54.79M	60.45M	69.00M	59.99M	57.42M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.